Malta Thalidomide Affair Opens New Malta–Africa Chapter on Pharmaceutical Accountability By Raymond Enoch
The painful history of the thalidomide tragedy in Malta has taken on a broader international dimension following the presentation of The Malta Thalidomide Affair by its author and survivor, Anatole Baldacchino, to the Honorary Consul of the Republic of Côte d’Ivoire to Malta, Mrqs. Anthony C. Coleiro.
The presentation, held in Ħaż-Żebbuġ, brought together historical memory, personal testimony and an emerging Malta-Africa perspective on one of the most troubling episodes in modern medical history, raising fresh questions about pharmaceutical responsibility, public health, regulation and accountability.
Baldacchino, himself a survivor of the thalidomide tragedy, presented the book to Coleiro during a meeting that explored how Malta’s experience could contribute to wider conversations across Africa and Europe on the movement, marketing and regulation of medicines.
The book is the product of extensive research into the circumstances surrounding the presence of thalidomide in Malta and combines historical investigation with the author’s personal experience of living with the consequences of the drug.
Beyond documenting the Maltese experience, the presentation opened a significant African dimension to the historical record.
Research by Professor Julie Parle, together with Ludger Wimmelbücker and drawing on wider scholarship including the work of Susanne Klausen, has established that the history of thalidomide in Africa cannot be viewed simply through the lens of Western Europe.
Studies of Southern Africa and other parts of the continent indicate that thalidomide-containing medicines were marketed, distributed or considered for distribution in several African territories during the late 1950s and early 1960s.
However, Africa did not record a continent-wide epidemic of congenital deformities on the scale experienced in some Western countries.
Researchers have attributed that difference to a complex combination of factors, including patterns of pharmaceutical marketing and distribution, access to healthcare, regulatory structures, colonial and post-war economic conditions, as well as the availability and use of different thalidomide preparations.
That distinction, according to the participants, is crucial to understanding Africa’s place in the thalidomide story.
Rather than being simply a continent that was “spared” the tragedy, Africa formed part of the complex international network through which pharmaceutical products moved and were introduced into different health systems.
For West Africa and Côte d’Ivoire in particular, the historical record provides an opportunity to examine how pharmaceutical products moved between Europe and African territories during the period surrounding independence and the emergence of modern African health and regulatory institutions.
The discussion consequently elevated the book presentation beyond a ceremonial exchange, turning it into a platform for knowledge diplomacy and historical reflection between Malta and Africa.
Coleiro, in his capacity as Honorary Consul of Côte d’Ivoire to Malta and Ambassador for the State of the African Diaspora, said the historical lessons contained in Baldacchino’s work transcend national boundaries.
> “Historical memory has no borders. The story documented by Anatole Baldacchino is fundamentally Maltese, but its implications extend far beyond Malta.”
He stressed that understanding the wider African dimension of the thalidomide experience could contribute to contemporary debates on public health, pharmaceutical responsibility and the protection of future generations.
The occasion was also attended by H.E. Anthony De Bono, former Ambassador of Malta to the Hashemite Kingdom of Jordan and Perpetual Ambassador of the Commonwealth Telecommunications Organisation (CTO), whose diplomatic and public-service experience added further depth to the engagement.
For Baldacchino, the presentation represents an important opportunity to ensure that the Maltese thalidomide experience is preserved as part of the country’s historical record while connecting it with a much larger international story.
The engagement also underscores the potential for Malta-Africa relations to extend beyond conventional areas such as diplomacy, trade and development into history, research, culture, public health and knowledge exchange.
At the heart of the discussion is a lasting lesson from the thalidomide tragedy: medical innovation without accountability can carry consequences across generations.
The Malta Thalidomide Affair therefore emerges not only as a record of a painful Maltese chapter, but as a wider warning on the responsibility of governments, pharmaceutical companies, regulators and health institutions to place human life and patient safety at the centre of medical decision-making.
